http://www.pharmachemm.com
Home > Industry Information > Apixaban Eliquis
Industry Information

Apixaban Eliquis

2019-05-31

Apixaban is an oral, direct, and highly selective factor Xa (FXa) inhibitor of both free and bound FXa, as well as prothrombinase, independent of antithrombin III for the prevention and treatment of thromboembolic diseasesLabel,2. It is marketed under the name EliquisLabel,3. Apixaban was approved by the FDA on December 28, 20123.
Previous: Apixaban intermediate cas 27143-07-3 Next: Tianeptine is an antidepressant agent

Related Products

Related Industry Information
Communicate with Supplier?Supplier
Mr. Vid Mr. Mr. Vid
What can I do for you?
Contact Supplier